GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AddLife AB (OSTO:ALIF B) » Definitions » Cash Flow from Financing

AddLife AB (OSTO:ALIF B) Cash Flow from Financing : kr-550 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is AddLife AB Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2024, AddLife AB paid kr12 Mil more to buy back shares than it received from issuing new shares. It received kr6 Mil from issuing more debt. It paid kr0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received kr0 Mil from paying cash dividends to shareholders. It spent kr44 Mil on other financial activities. In all, AddLife AB spent kr50 Mil on financial activities for the three months ended in Mar. 2024.


AddLife AB Cash Flow from Financing Historical Data

The historical data trend for AddLife AB's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AddLife AB Cash Flow from Financing Chart

AddLife AB Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.20 -372.50 2,070.00 134.00 -554.00

AddLife AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -54.00 -128.00 -89.00 -283.00 -50.00

AddLife AB Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

AddLife AB's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

AddLife AB's Cash from Financing for the quarter that ended in Mar. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-550 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AddLife AB  (OSTO:ALIF B) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

AddLife AB's issuance of stock for the three months ended in Mar. 2024 was kr-12 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

AddLife AB's repurchase of stock for the three months ended in Mar. 2024 was kr0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

AddLife AB's net issuance of debt for the three months ended in Mar. 2024 was kr6 Mil. AddLife AB received kr6 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

AddLife AB's net issuance of preferred for the three months ended in Mar. 2024 was kr0 Mil. AddLife AB paid kr0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

AddLife AB's cash flow for dividends for the three months ended in Mar. 2024 was kr0 Mil. AddLife AB received kr0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

AddLife AB's other financing for the three months ended in Mar. 2024 was kr-44 Mil. AddLife AB spent kr44 Mil on other financial activities.


AddLife AB Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of AddLife AB's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


AddLife AB (OSTO:ALIF B) Business Description

Traded in Other Exchanges
Address
Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals & laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.

AddLife AB (OSTO:ALIF B) Headlines

No Headlines